Dr. Yamini P. Chennu, MD

Dr. Chennu practices at Tarrant Neurology Consultants, P.A. in Fort Worth, Texas.

Dr. Chennu's NPI, 1548210263, was assigned on May 11, 2006. Dr. Chennu graduated from Second Tashkent State Medical Institute in 1993. Dr. Chennu holds Texas license N0696.

Dr. Chennu's primary practice is Tarrant Neurology Consultants, P.A., at 713 Grainger St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 336-3968.

Dr. Chennu's primary practice is Tarrant Neurology Consultants, P.A. in Fort Worth, Texas. Dr. Chennu is also affiliated with Texas Health Fort Worth. The medical group on file is Tarrant Neurology Consultants. Dmand AI also links Dr. Chennu to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chennu practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chennu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chennu is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Chennu's licenses on file in 2 states: Texas and Virginia.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Chennu treats.

CMS data shows 1,776 Medicare services from Dr. Chennu across 12 procedure codes in 2024, for 767 Medicare patients. Medicare paid $221,756 for them.

CMS counts 767 Medicare patients who saw Dr. Chennu in 2024. The largest group is 75 to 84, with 293 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chennu's median patient age at 68, with 62% women.

In 2024, Dr. Chennu wrote 2,792 Medicare Part D claims for 506 patients. 93% of them were for generic drugs. CMS names the drug for 2,481 of them, across 41 drugs with 11 or more claims each, at $778,435 in total drug cost. In 2023, CMS named 2,774 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Chennu for performance year 2024, reported as part of a group. Dr. Chennu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,635 general payments to Dr. Chennu from 85 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,383.

Dmand AI lists 1 award for Dr. Chennu, most recently CMS Stage 1 EHR in 2013.

Dr. Chennu graduated from Second Tashkent State Medical Institute in 1993.

Dr. Chennu is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.